Bupivacaine Hydrochloride Injection, Solution
Product Images NDC 71288-726

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bupivacaine Hydrochloride (NDC 71288-726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel – 0.25% Bupivacaine Hydrochloride Injection, Usp 125 mg Per 50 mL Carton (Bupiv 125mg 50ml Carton)

Principal Display Panel – 0.25% Bupivacaine Hydrochloride Injection, Usp 125 mg Per 50 mL Carton (Bupiv 125mg 50ml Carton)
This is a description of a medication called Bupivacaine Hydrochloride Injection. It is a solution with a concentration of 0.25%, containing 125 mg of the active ingredient per 50 mL (25 mg per mL). It is intended for use in infiltration and nerve block procedures, but not for caudal, epidural, or spinal anesthesia. The medication is supplied in a 1x50mL multiple-dose vial. Each mL of the solution contains 2. mg of bupivacaine hydrochloride, along with methylparaben and sodium chloride in water for injection. The pH of the solution is adjusted with sodium hydroxide, hydrofluoric acid, or hydrochloric acid. The dosage information is provided in the package insert. The medication should be stored at room temperature, between 20°C and 25°C (68°F and 77°F), with excursions permitted between 15°C and 30°C (59°F and 86°F). It is sterile and nonpyrogenic. The container closure does not contain natural rubber latex.*
FDA Label Image

Principal Display Panel – 0.25% Bupivacaine Hydrochloride Injection, Usp 125 mg Per 50 mL Vial Label (Bupiv 125mg 50ml Vial)

Principal Display Panel – 0.25% Bupivacaine Hydrochloride Injection, Usp 125 mg Per 50 mL Vial Label (Bupiv 125mg 50ml Vial)
FDA Label Image

Principal Display Panel – 0.5% Bupivacaine Hydrochloride Injection, Usp 250 mg Per 50 mL Carton (Bupiv 250mg 50ml Carton)

Principal Display Panel – 0.5% Bupivacaine Hydrochloride Injection, Usp 250 mg Per 50 mL Carton (Bupiv 250mg 50ml Carton)
This is a description of a medication called Bupivacaine Hydrochloride Injection, USP with a concentration of 0.5%. It comes in a 50 mL multiple dose vial and contains 250 mg of Bupivacaine Hydrochloride, with a dosage of 5 mg per mL. This medication is intended for nerve blocks but should not be used for caudal, epidural, or spinal anesthesia. It is stored at a temperature between 20°C to 25°C and is sterile and nonpyrogenic. The container closure does not contain natural rubber latex. The contact information for the manufacturer is provided at the bottom.*
FDA Label Image

Principal Display Panel – 0.5% Bupivacaine Hydrochloride Injection, Usp 250 mg Per 50 mL Vial Label (Bupiv 250mg 50ml Vial)

Principal Display Panel – 0.5% Bupivacaine Hydrochloride Injection, Usp 250 mg Per 50 mL Vial Label (Bupiv 250mg 50ml Vial)
FDA Label Image

Structural Formula (Structure)

Structural Formula (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.